Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis
Marzia Caproni(University of Florence), Paolo Fabbri, Walter Volpi, Alessandra Frezzolini(Istituto Dermopatico dell'Immacolata), Emiliano Schincaglia(University of Florence), Emanuela Barletta(University of Florence), Donatella Schena(University of Verona), Daniele Torchia(University of Florence), Clara De Simone(IRCCS San Camillo Hospital), Aurora Parodi(Ospedale Policlinico San Martino), Pietro Quaglino(Department of Medical Sciences), Angelo Valerio Marzano(University of Milan)
Cited by 136
Related Papers
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
|JAMA Dermatology|2015|452
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
|European Journal of Cancer|2017|449